Answers are grounded in this paper and cite their sources.
: 0.125 μg/ml), with no cross-resistance to any of the seven comparator antimicrobials. Our data support the initiation of the global zoliflodacin phase 3 randomized controlled clinical trial for uncomplicated gonorrhea.
No takes yet. Share an insight, caveat, or question.
Jacobsson et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: